[1]张国庆,吴志平,郑丹,等.高分级颅内破裂动脉瘤血管内介入治疗预后的影响因素[J].中国临床神经外科杂志,2023,28(10):649-652.[doi:10.13798/j.issn.1009-153X.2023.10.012]
点击复制

高分级颅内破裂动脉瘤血管内介入治疗预后的影响因素()
分享到:

《中国临床神经外科杂志》[ISSN:1009-153X/CN:42-1603/TN]

卷:
28
期数:
2023年10期
页码:
649-652
栏目:
经验介绍
出版日期:
2023-10-31

文章信息/Info

文章编号:
1009-153X(2023)10-0649-04
作者:
张国庆吴志平郑丹何立建廖明兴
558099贵州,黔南州人民医院神经外科(张国庆、吴志平、郑丹、何立建、廖明兴)
关键词:
高分级颅内破裂动脉瘤动脉瘤性蛛网膜下腔出血血管内介入治疗预后影响因素
分类号:
R 743.9; R815.2
DOI:
10.13798/j.issn.1009-153X.2023.10.012
文献标志码:
B
摘要:
目的 探讨高分级颅内破裂动脉瘤血管内介入治疗的预后及其影响因素。方法 回顾性分析2020年9月至2022年9月血管内介入术治疗的156例WFNS分级Ⅳ~Ⅴ级颅内破裂动脉瘤的临床资料。根据出院时改良Rankin量表(mRS)评分评估预后,mRS评分≤2分为预后良好,>2分为预后不良。采用多因素logistic回归模型分析预后不良的危险因素。结果 156例中,出院时预后不良68例(43.59%),预后良好88例。多因素logistic回归分析显示,高血压、年龄≥70岁及SEBES评分≥3分为高分级颅内破裂动脉瘤病人出院时预后不良的独立危险因素(P<0.05)。结论 WFNS分级Ⅳ~Ⅴ级颅内破裂动脉瘤病人血管内介入术治疗的预后不良发生率较高,尤其是合并高血压、年龄≥70岁及SEBES评分≥3分的病人,预后不良风险更高。

参考文献/References:

[1]SHARMA D. Perioperative management of aneurysmal subarachnoid hemorrhage [J]. Anesthesiology, 2020, 133(6):1283-1305.
[2]李兵兵,洪景芳,李克磊,等. 动脉瘤性蛛网膜下腔出血对脑静脉循环的影响[J]. 中国临床神经外科杂志,2021,26(1):17-19.
[3]NEIFERT SN, CHAPMAN EK, MARTINI ML, et al. Aneurysmal subarachnoid hemorrhage: the last decade [J]. TranslStroke Res, 2021, 12(3): 428-446.
[4]TAWK RG, HASAN TF, D'SOUZA CE, et al. Diagnosis and treatment of unruptured intracranial aneurysms and aneurysmal subarachnoid hemorrhage [J]. Mayo Clin Proc, 2021,96(7): 1970-2000.
[5]BEIGHLEY A, GLYNN R, SCULLEN T, et al. Aneurysmal subarachnoid hemorrhage during pregnancy: a comprehensive and systematic review of the literature [J]. Neurosurg Rev, 2021, 44(5): 2511-2522.
[6]DE JONG G, AQUARIUS R, SANAAN B, et al. Prediction models in aneurysmal subarachnoid hemorrhage: forecasting clinical outcome with artificial intelligence [J]. Neurosurgery, 2021, 88(5): E427-E434.
[7]中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组,中华医学会神经病学分会神经血管介入协作组. 中国蛛网膜下腔出血诊治指南2019[J]. 中华神经科杂志,2019,52(12):16.
[8]BALANA B, BOUCHIER B, RITZENTHALER T. The management of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage [J]. Rev Neurol (Paris), 2022, 178(1-2): 64-73.
[9]LECLERC A, GOIA A, GILARD V, et al. Massive nonaneurysmal subarachnoid hemorrhage after cervical carotid angioplasty and stenting: a case report and review of the literature [J]. Neurochirurgie, 2022, 68(3): 342-346.
[10]KANJILAL S, MEHROTRA A, SINGH V, et al. Non-aneurysmal subarachnoid hemorrhage: is the deep venous systemthe hidden culprit [J]. Acta Neurochir (Wien), 2022, 164(7):1827-1835.
[11]SEBK M, HOSTETTLER IC, KELLER E, et al. Prehemorrhage antiplatelet use in aneurysmal subarachnoid hemorrhage and impact on clinical outcome [J]. Int J Stroke, 2022, 17(5): 5.
[12]BSAT S, CHANBOUR H, BSAT A, et al. Clinical utility of degradomics as predictors of complications and clinical outcome in aneurysmal subarachnoid hemorrhage [J]. J Integr Neurosci, 2021, 20(2): 489-497.
[13]BSAT S, CHANBOUR H, ALOMARI S, et al. Can we improve the prediction of complications and outcome in aneurysmal subarachnoid hemorrhage: the clinical implications of serum proteomics [J]. J Integr Neurosci, 2020, 19(4): 711-717.
[14]AHN SH, SAVARRAJ JP, PERVEZ M, et al. The subarachnoid hemorrhage early brain edema score predicts delayed cerebral ischemia and clinical outcomes [J]. Neurosurgery, 2018, 83(1): 137-145.
[15]SAVARRAJ J, PARSHA K, HERGENROEDER G, et al. Early brain injury associated with systemic inflammation after subarachnoid hemorrhage [J]. Neurocrit Care, 2018, 28(2): 203-211.
[16]DILVESI D, CIGIC T, PAPIC V, et al. The Fisher grade in predicting a degree of cerebral vasospasm in patients after intracranial aneurysm rupture [J]. Vojnosanit Pregl, 2016, 73(4): 349-352.

相似文献/References:

[1]郭 芳 张 铭 李中振 梁恩和.动脉瘤性蛛网膜下腔出血后分流依赖性脑积水的危险因素分析[J].中国临床神经外科杂志,2016,(02):73.[doi:10.13798/j.issn.1009-153X.2016.02.004]
 GUO Fang,ZHANG Ming,LI Zhong-zhen,et al.Risk factors related to shunt-dependent hydrocephalus in patients with aneurysmal subarachnoid hemorrhage[J].,2016,(10):73.[doi:10.13798/j.issn.1009-153X.2016.02.004]
[2]邹志鹏 杨 海 夏军勇 张化明 张 华 魏 恒 马江红.行血管内治疗的高龄颅内动脉瘤患者脑血管痉挛的临床分析[J].中国临床神经外科杂志,2015,(07):401.[doi:10.13798/j.issn.1009-153X.2015.07.006]
 ZOU Zhi-peng,YANG Hai,XIA Jun-yong,et al.Clinical analysis of symptomatic cerebral vasospasm after endovascular treatment of ruptured cerebral aneurysms in patients of 70 and over 70 years[J].,2015,(10):401.[doi:10.13798/j.issn.1009-153X.2015.07.006]
[3]郎胜坤 许厚银 董月青 马铁柱 孙 艳 郝芊芊 王慧敏.磁共振灌注成像评估蛛网膜下腔出血后脑血管痉挛的价值[J].中国临床神经外科杂志,2016,(09):517.[doi:10.13798/j.issn.1009-153X.2016.09.002]
 LANG Sheng-kuan,XU Hou-yin,DONG Yue-qing,et al.Evaluation of cerebral vasospasm after aneurysmal subarachnoid hemorrhage by magnetic resonance perfusion weighted imaging[J].,2016,(10):517.[doi:10.13798/j.issn.1009-153X.2016.09.002]
[4]王世龙,赵 冬,许 晖,等.血脂水平与动脉瘤性蛛网膜下腔出血后迟发性脑缺血的相关性[J].中国临床神经外科杂志,2016,(11):685.[doi:10.13798/j.issn.1009-153X.2016.11.011]
 WANG Shi-long,ZHAO Dong,XU Hui,et al.Relationship of serum lipid with delayed cerebral ischemia following the aneurysmal subarachnoid hemorrhage[J].,2016,(10):685.[doi:10.13798/j.issn.1009-153X.2016.11.011]
[5]潘逸珩 雷军荣 段 波 魏德胜 陈 亮 陈志明 秦 军.动脉瘤性蛛网膜下腔出血术后脑梗死的临床特点及其发生的危险因素分析[J].中国临床神经外科杂志,2017,(01):4.[doi:10.13798/j.issn.1009-153X.2017.01.002]
 PAN Yi-heng,LEI Jun-rong,DUAN Bo,et al.Analysis of clinical features of postoperative cerebral infarction and the factors related to it in patients with aneurysmal subarachnoid hemorrhage[J].,2017,(10):4.[doi:10.13798/j.issn.1009-153X.2017.01.002]
[6]谢 飞 陈志远 曾家良 叶勇强.DSA联合血清SICAM-1评估颅内破裂动脉瘤术后脑血管痉挛的效果[J].中国临床神经外科杂志,2017,(09):617.[doi:10.13798/j.issn.1009-153X.2017.09.003]
 XIE Fei CHEN Zhi-yuan ZENG Jia-liang,Ye Yong-qiang.Application of DSA combined with serum SICAM-1 to the evaluation of cerebral vasospasm after SAH due to aneurysmal rupture[J].,2017,(10):617.[doi:10.13798/j.issn.1009-153X.2017.09.003]
[7]阮 东 王 芳 郭丽蕊 彭红梅 陈谦学 刘宝辉.C-反应蛋白与动脉瘤性蛛网膜下腔出血临床预后的关系[J].中国临床神经外科杂志,2017,(09):626.[doi:10.13798/j.issn.1009-153X.2017.09.006]
 RUAN Dong,WANG Fang,GUO Li-rui,et al.Relationship between serum level of C-reactive protein and prognoses in patients with aneurysmal subarachnoid hemorrhage[J].,2017,(10):626.[doi:10.13798/j.issn.1009-153X.2017.09.006]
[8]阿库布千、李祥龙、罗 鑫、周 江、李 昊、刘 亮、 陈礼刚、夏祥国.亚洲人群动脉瘤性蛛网膜下腔出血高压氧辅助治疗疗效的Meta分析[J].中国临床神经外科杂志,2017,(11):757.[doi:10.13798/j.issn.1009-153X.2017.11.008]
 AKU Bu-qian,LI Xiang-long,LUO Xin,et al.Meta-analysis of effects of hyperbaric oxygen therapy on clinical outcomes in Asian patients with aneurysmal subarachnoid hemorrhage[J].,2017,(10):757.[doi:10.13798/j.issn.1009-153X.2017.11.008]
[9]张 兰 库洪彬 王 敏 周 燕.动脉瘤性蛛网膜下腔出血病人血清sLOX-1、netrin-1水平变化及其与病人预后的关系[J].中国临床神经外科杂志,2020,(06):377.[doi:10.13798/j.issn.1009-153X.2020.06.013]
 ZHANG Lan,KU Hong-bin,WANG Min,et al.Relationship between serum levels of sLOX-1 and netrin-1 and progosis of patients with aneurysmal subarachnoid hemorrhage[J].,2020,(10):377.[doi:10.13798/j.issn.1009-153X.2020.06.013]
[10]李兵兵 洪景芳 李克磊 张 灏 张尚明 王守森.动脉瘤性蛛网膜下腔出血对脑静脉循环的影响[J].中国临床神经外科杂志,2021,26(01):17.[doi:10.13798/j.issn.1009-153X.2021.01.006]
 LI Bing-bing,HONG Jing-fang,LI Ke-lei,et al.Effects of aneurysmal subarachnoid hemorrhage on cerebral venous circulation[J].,2021,26(10):17.[doi:10.13798/j.issn.1009-153X.2021.01.006]

备注/Memo

备注/Memo:
(2023-02-23收稿,2023-05-15修回)
基金项目:贵州省卫生厅项目(GW-2012B021)
通讯作者:吴志平,E-mail:gzwzp@foxmail.com
更新日期/Last Update: 2023-10-31